D-1545-2022 Class II Terminated

Recalled by CIPLA — Warren, NJ

Recall Details

Product Type
Drugs
Report Date
October 5, 2022
Initiation Date
September 15, 2022
Termination Date
January 10, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
641,160 ampules

Product Description

Budesonide Inhalation Suspension 0.25mg/2mL, For Inhalation Only, Rx Only, 1 envelope x five 2 mL Single Dose Ampules per pouch, Sterile Suspension, Manufactured by: Cipla Ltd., India, Manufactured for Cipla USA Inc., Warren NJ, NDC# 69097-318-86.

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide in the USA and Puerto Rico

Code Information

Lot #s: GA20080, GA20081, GA20094, Exp. 01/2024